Grant: Engage Plus Grants Program
Queen's University
$12,500.00
Synthesis of deuterium labelled compounds for potential use in pain therapy
FY 2016-17
Summary
Before the synthesis of urea in 1828, organic molecules were available only through biological processes. Continuous advances in the chemical sciences has led to development of methods that can be used for the design and synthesis of complex molecules. Many of these synthetic molecules have found wide range of applications including as crop protection agents, cosmetics, food preservatives and medicines. Among several classes of synthetic molecules, deuterated medicinal compounds are of extraordinary interest due to their applications as modern pharmaceutical agents. However, their methods of preparation are challenging and require expensive starting materials. For this reason, there has been special interest in developing new methods for the synthesis of deuterated medicinal compounds for testing against new diseases or for many other biological studies. Through this proposal, we plan to develop efficient synthetic methodologies to prepare biologically important deuterated pharmaceutical compounds (e.g. Silodosin, Canagliflozen, Ledipasvir, Vilazodone) for their use in the pharmaceutical industry. Previous methods such as the directed ortho metalation (DoM) reaction, discovered and developed in our laboratories, are being used by the pharmaceutical industry (e.g. Monsanto, Pfizer, BMS, Merck) for the multikilogram commercial production of drugs, agrochemicals, and other commodity chemicals. This research proposal aims to help produce less expensive and less toxic drugs. Hence provide health and economic benefits to Canadians. Through this work we will also train highly qualified workers for the Canadian labor market.
Program
Engage Plus Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
493803-2016
Name nom
Snieckus, Victor
Department département
Chemistry
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Synthesis of deuterium labelled compounds for potential use in pain therapy
Keyword
NSERC
Application summary
Before the synthesis of urea in 1828, organic molecules were available only through biological processes. Continuous advances in the chemical sciences has led to development of methods that can be used for the design and synthesis of complex molecules. Many of these synthetic molecules have found wide range of applications including as crop protection agents, cosmetics, food preservatives and medicines. Among several classes of synthetic molecules, deuterated medicinal compounds are of extraordinary interest due to their applications as modern pharmaceutical agents. However, their methods of preparation are challenging and require expensive starting materials. For this reason, there has been special interest in developing new methods for the synthesis of deuterated medicinal compounds for testing against new diseases or for many other biological studies. Through this proposal, we plan to develop efficient synthetic methodologies to prepare biologically important deuterated pharmaceutical compounds (e.g. Silodosin, Canagliflozen, Ledipasvir, Vilazodone) for their use in the pharmaceutical industry. Previous methods such as the directed ortho metalation (DoM) reaction, discovered and developed in our laboratories, are being used by the pharmaceutical industry (e.g. Monsanto, Pfizer, BMS, Merck) for the multikilogram commercial production of drugs, agrochemicals, and other commodity chemicals. This research proposal aims to help produce less expensive and less toxic drugs. Hence provide health and economic benefits to Canadians. Through this work we will also train highly qualified workers for the Canadian labor market.